# Icahn Enterprises L.P.: financial statements, quarterly

IEP · Nasdaq · CIK 813762 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/iep.md) · [Financials](/companies/iep/financials.md) · [Filings](/companies/iep/filings.md) · [Insiders](/companies/iep/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/iep/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,010](/filings/0001558370-24-015065.md) | [2,696 d](/filings/0001104659-26-019821.md) | [2,470](/filings/0001558370-25-006771.md) | [2,201](/filings/0001558370-25-010094.md) | [2,791](/filings/0001104659-25-107057.md) | [2,558 d](/filings/0001104659-26-019821.md) | [1,867](/filings/0001104659-26-056376.md) | [2,369](/filings/0001104659-26-090605.md) | [2,725](/filings/0001104659-25-107057.md) | [2,697 d](/filings/0001104659-26-019821.md) | [2,206](/filings/0001104659-26-056376.md) | [2,975](/filings/0001104659-26-090605.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [209](/filings/0001558370-24-015065.md) | [199 d](/filings/0001104659-26-019821.md) | [193](/filings/0001558370-25-006771.md) | [183](/filings/0001558370-25-010094.md) | [202](/filings/0001104659-25-107057.md) | [205 d](/filings/0001104659-26-019821.md) | [201](/filings/0001104659-26-056376.md) | [207](/filings/0001104659-26-090605.md) | [218](/filings/0001104659-25-107057.md) | [211 d](/filings/0001104659-26-019821.md) | [209](/filings/0001104659-26-056376.md) | [203](/filings/0001104659-26-090605.md) |
| Interest expense | $m | [148](/filings/0001558370-24-015065.md) | [128 d](/filings/0001104659-26-019821.md) | [136](/filings/0001558370-25-006771.md) | [128](/filings/0001558370-25-010094.md) | [130](/filings/0001104659-25-107057.md) | [129 d](/filings/0001104659-26-019821.md) | [128](/filings/0001104659-26-056376.md) | [129](/filings/0001104659-26-090605.md) | [122](/filings/0001104659-25-107057.md) | [125 d](/filings/0001104659-26-019821.md) | [123](/filings/0001104659-26-056376.md) | [121](/filings/0001104659-26-090605.md) |
| Income tax | $m | [96.0](/filings/0001558370-24-015065.md) | [8.0 d](/filings/0001104659-26-019821.md) | [7.0](/filings/0001558370-25-006771.md) | [4.0](/filings/0001558370-25-010094.md) | [(13.0)](/filings/0001104659-25-107057.md) | [(23.0) d](/filings/0001104659-26-019821.md) | [(74.0)](/filings/0001104659-26-056376.md) | [(45.0)](/filings/0001104659-26-090605.md) | [127](/filings/0001104659-25-107057.md) | [(27.0) d](/filings/0001104659-26-019821.md) | [(49.0)](/filings/0001104659-26-056376.md) | [2.0](/filings/0001104659-26-090605.md) |
| Net income | $m | [(6.0)](/filings/0001558370-24-015065.md) | [(139) d](/filings/0001104659-26-019821.md) | [(38.0)](/filings/0001558370-25-006771.md) | [(331)](/filings/0001558370-25-010094.md) | [22.0](/filings/0001104659-25-107057.md) | [(98.0) d](/filings/0001104659-26-019821.md) | [(422)](/filings/0001104659-26-056376.md) | [(165)](/filings/0001104659-26-090605.md) | [287](/filings/0001104659-25-107057.md) | [1.0 d](/filings/0001104659-26-019821.md) | [(459)](/filings/0001104659-26-056376.md) | [(355)](/filings/0001104659-26-090605.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.9](/filings/0001558370-23-017606.md) | [3.0](/filings/0001558370-25-001612.md) | [2.5](/filings/0001558370-24-007379.md) | [2.2](/filings/0001558370-24-011371.md) | [2.3](/filings/0001558370-24-015065.md) | [2.6](/filings/0001104659-26-019821.md) | [2.2](/filings/0001558370-25-006771.md) | [1.8](/filings/0001558370-25-010094.md) | [1.8](/filings/0001104659-25-107057.md) | [1.5](/filings/0001104659-26-090605.md) | [1.3](/filings/0001104659-26-056376.md) | [1.2](/filings/0001104659-26-090605.md) |
| Total assets | $bn | [21.8](/filings/0001558370-23-017606.md) | [20.9](/filings/0001558370-25-001612.md) | [20.1](/filings/0001558370-24-007379.md) | [18.0](/filings/0001558370-24-011371.md) | [17.4](/filings/0001558370-24-015065.md) | [16.3](/filings/0001104659-26-019821.md) | [15.5](/filings/0001558370-25-006771.md) | [14.8](/filings/0001558370-25-010094.md) | [14.8](/filings/0001104659-25-107057.md) | [14.2](/filings/0001104659-26-090605.md) | [12.9](/filings/0001104659-26-056376.md) | [12.9](/filings/0001104659-26-090605.md) |
| Total liabilities | $bn | [15.1](/filings/0001558370-23-017606.md) | [14.8](/filings/0001558370-25-001612.md) | [14.4](/filings/0001558370-24-007379.md) | [12.6](/filings/0001558370-24-011371.md) | [12.6](/filings/0001558370-24-015065.md) | [11.7](/filings/0001104659-26-019821.md) | [11.7](/filings/0001558370-25-006771.md) | [11.4](/filings/0001558370-25-010094.md) | [11.4](/filings/0001104659-25-107057.md) | [10.8](/filings/0001104659-26-090605.md) | [10.6](/filings/0001104659-26-056376.md) | [10.7](/filings/0001104659-26-090605.md) |
| Shareholders' equity | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: not reported

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,627 d](/filings/0001558370-24-015065.md) | [115 d](/filings/0001104659-26-019821.md) | [(251)](/filings/0001558370-25-006771.md) | [893 d](/filings/0001558370-25-010094.md) | [(54.0) d](/filings/0001104659-25-107057.md) | [244 d](/filings/0001104659-26-019821.md) | [(182)](/filings/0001104659-26-056376.md) | [275 d](/filings/0001104659-26-090605.md) | [15.0 d](/filings/0001104659-25-107057.md) | [(421) d](/filings/0001104659-26-019821.md) | [397](/filings/0001104659-26-056376.md) | [116 d](/filings/0001104659-26-090605.md) |
| Capital expenditure | $m | [70.0](/filings/0001558370-24-015065.md) | [102 d](/filings/0001104659-26-019821.md) | [68.0](/filings/0001558370-25-006771.md) | [66.0](/filings/0001558370-25-010094.md) | [58.0](/filings/0001104659-25-107057.md) | [88.0 d](/filings/0001104659-26-019821.md) | [88.0](/filings/0001104659-26-056376.md) | [96.0](/filings/0001104659-26-090605.md) | [82.0](/filings/0001104659-25-107057.md) | [75.0 d](/filings/0001104659-26-019821.md) | [114](/filings/0001104659-26-056376.md) | [80.0](/filings/0001104659-26-090605.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported

## Shares

| Line item | Unit | period not labelled (2010-06-30) | period not labelled (2010-09-30) | period not labelled (2011-03-31) | Q2 FY2011 (2011-06-30) | Q3 FY2011 (2011-09-30) | Q1 FY2012 (2012-03-31) | Q2 FY2012 (2012-06-30) | Q3 FY2012 (2012-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [85.0](/filings/0000813762-11-000033.md) | [90.0](/filings/0000813762-11-000048.md) | [91.0](/filings/0000813762-12-000021.md) | [92.0](/filings/0000813762-12-000046.md) | [87.0](/filings/0000813762-12-000064.md) | [97.0](/filings/0000813762-12-000021.md) | [105](/filings/0000813762-12-000046.md) | [102](/filings/0000813762-12-000064.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 710,915,093 at 2026-08-04, from the cover of the [10-Q filed 2026-08-05](/filings/0001104659-26-090605.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.